Want to see IBEX full AI Analyst Report?
Top Page
IBEX
(NASDAQ:IBEX)
Select Model
Select Model
Rating:76Outperform
Price Target:
$42.00
▲(14.66% Upside)
Action:Reiterated
Date:09/12/26
IBEX scores well primarily on solid financial performance (growth, improved profitability, and much lower leverage) and a very constructive earnings update with upbeat FY27 guidance and AI-led momentum. Technicals are supportive with price above major moving averages and positive MACD, while valuation is reasonable on a 10.8 P/E but lacks a stated dividend yield. The main constraints on the score are uneven margin/cash-conversion quality and recent quarter margin/EPS pressure.
Positive Factors
Revenue Growth and AI Expansion
Strong historical growth combined with double-digit fiscal 2027 guidance indicates continued demand for IBEX’s outsourced CX services. Early AI deployments are expanding the addressable offering, helping the company win new logos and deepen relationships with existing clients over time.
Negative Factors
Adjusted EBITDA Margin Pressure
The quarterly margin decline shows that growth investments and operational changes are currently diluting profitability. Although management expects expansion to resume, continued implementation costs or delivery inefficiencies could limit earnings conversion while new programs mature.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth and AI Expansion
Strong historical growth combined with double-digit fiscal 2027 guidance indicates continued demand for IBEX’s outsourced CX services. Early AI deployments are expanding the addressable offering, helping the company win new logos and deepen relationships with existing clients over time.
Read all positive factors
IBEX (IBEX) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$528.49M
Dividend YieldN/A
Average Volume (3M)117.20K
Price to Earnings (P/E)11.5
Beta (1Y)1.06
Revenue Growth15.37%
EPS Growth34.60%
CountryUS
Employees35,000
SectorTechnology
Sector Strength88
IndustryInformation Technology Services
Share Statistics
EPS (TTM)3.45
Shares Outstanding13,278,634
10 Day Avg. Volume135,298
30 Day Avg. Volume117,199
Financial Highlights & Ratios
PEG Ratio0.24
Price to Book (P/B)2.39
Price to Sales (P/S)0.63
P/FCF Ratio13.06
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$40.00Price Target Upside9.20% Upside
Rating ConsensusHold
Number of Analyst Covering1
EPS Forecast (FY)3.63
Revenue Forecast (FY)$678.51M
IBEX Business Overview & Revenue Model
Company Description
IBEX Limited is a global enterprise that specializes in delivering comprehensive, technology-powered solutions designed to manage the entire customer lifecycle for businesses. Their service portfolio is built around three core solutions: ibex Conn...
How the Company Makes Money
IBEX primarily makes money by providing outsourced CX/BPO services to client companies under service contracts. Revenue is generally earned through fees tied to operating customer engagement programs (e.g., staffing and managing contact center age...
IBEX Earnings Call Summary
Earnings Call Date:Sep 10, 2026
(Q4-2026)
| % Change Since: |
Next Earnings Date:Nov 05, 2026
Earnings Call Sentiment Positive
The call was strongly positive. IBEX reported record full-year revenue, profitability, cash flow, client retention, and broad-based vertical growth, while adding significant AI-agent traction and issuing growth guidance for fiscal 2027. The main negatives were fourth-quarter declines in GAAP net income, EPS, and adjusted EBITDA margin, along with nearshore growth challenges, lower telecommunications volume, and a higher normalized tax-rate outlook. Highlights significantly outweighed lowlights.Positive Updates
Record Quarterly and Full-Year Revenue
Fourth-quarter revenue reached a record $164.3 million, up 12% from $147.1 million in the prior-year quarter, marking the sixth straight quarter of double-digit revenue growth. Fiscal-year 2026 revenue reached a record $644.1 million, up 15.4% from $558.3 million.
Negative Updates
Fourth-Quarter GAAP Profit Decline
Fourth-quarter GAAP net income decreased to $8.7 million from $9.6 million in the prior-year quarter, while fully diluted GAAP EPS declined to $0.59 from $0.66. Results were primarily affected by training expenses related to new client wins, the temporary transfer of work from nearshore to offshore delivery centers, and higher fuel prices affecting utility and transportation expenses, particularly in the offshore region.
Read all updates
Q4-2026 Updates
Positive
Negative
Record Quarterly and Full-Year Revenue
Fourth-quarter revenue reached a record $164.3 million, up 12% from $147.1 million in the prior-year quarter, marking the sixth straight quarter of double-digit revenue growth. Fiscal-year 2026 revenue reached a record $644.1 million, up 15.4% from $558.3 million.
Read all positive updates
Company Guidance
For fiscal year 27, revenue is expected to be in the range of $700 to $715 million for 9% to 11% growth, and Adjusted EBITDA is expected to be in the range of $90 million to $94 million or 9% to 14% growth; for first quarter of fiscal year 27, revenue is expected to be in the range of $168 to $170 million, or 11 to 12% growth, and Adjusted EBITDA is expected to be in the range of $22 million to $23 million or 13% to 18% growth. Capital expenditures for the year are expected to be in the range of $25 million to $30 million, the normalized tax rate going forward is expected to be in the 20% to 22% range, DSOs are expected to remain stable in the low to mid seventies on a go forward basis, and adjusted EBITDA margins are expected to return to expanding in the first quarter of fiscal year 27.IBEX Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
74
Positive
Cash Flow
69
Positive
| Breakdown | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 644.08M | 558.27M | 508.57M | 523.12M | 492.85M |
| Gross Profit | 170.12M | 172.58M | 152.03M | 148.13M | 118.88M |
| EBITDA | 83.28M | 64.80M | 60.96M | 60.10M | 38.77M |
| Net Income | 46.33M | 36.86M | 33.66M | 31.58M | 21.46M |
Balance Sheet | |||||
| Total Assets | 309.13M | 273.21M | 293.90M | 293.32M | 294.18M |
| Cash, Cash Equivalents and Short-Term Investments | 32.57M | 15.35M | 62.72M | 57.43M | 48.83M |
| Total Debt | 62.44M | 69.75M | 67.02M | 78.90M | 105.54M |
| Total Liabilities | 138.91M | 138.91M | 128.10M | 143.36M | 180.72M |
| Stockholders Equity | 170.23M | 134.31M | 165.80M | 149.96M | 113.46M |
Cash Flow | |||||
| Free Cash Flow | 31.19M | 27.29M | 27.05M | 22.91M | 14.09M |
| Operating Cash Flow | 59.00M | 45.67M | 35.90M | 41.86M | 40.01M |
| Investing Cash Flow | -27.81M | -18.38M | -8.86M | -19.04M | -25.92M |
| Financing Cash Flow | -13.93M | -74.66M | -21.73M | -13.61M | -22.13M |
IBEX Technical Analysis
Positive
36.63
Price Trends
35.98
Positive
33.14
Positive
33.06
Positive
Market Momentum
0.96
Negative
66.98
Neutral
68.90
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IBEX, the sentiment is Positive. The current price of 36.63 is below the 20-day moving average (MA) of 37.52, above the 50-day MA of 35.98, and above the 200-day MA of 33.06, indicating a bullish trend. The MACD of 0.96 indicates Negative momentum. The RSI at 66.98 is Neutral, neither overbought nor oversold. The STOCH value of 68.90 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IBEX.
IBEX Risk Analysis
IBEX disclosed 49 risk factors in its most recent earnings report. IBEX reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
IBEX Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | $528.49M | 11.54 | 29.46% | ― | 15.37% | 34.60% | |
68 Neutral | $1.83B | 37.21 | 37.78% | ― | 39.02% | 0.49% | |
67 Neutral | $273.16M | 16.89 | 22.15% | 4.37% | -9.12% | 5.60% | |
65 Neutral | $746.33M | 6.84 | 24.65% | 55.81% | 11.38% | 69.06% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
56 Neutral | $252.00M | 14.53 | 19.22% | ― | -26.52% | 30.98% | |
47 Neutral | $176.46M | -0.41 | 134.79% | ― | -0.61% | -405.05% |
* Technology Sector Average
IBEX
IBEX
40.49
1.64
4.22%
INOD
Innodata
55.24
-10.43
-15.88%
HCKT
The Hackett Group
11.49
-8.57
-42.72%
UIS
Unisys
2.50
-1.49
-37.34%
TSSI
TSS
8.45
-7.55
-47.19%
TASK
TaskUs
8.24
-3.10
-27.33%
IBEX Corporate Events
Business Operations and StrategyFinancial DisclosuresPrivate Placements and Financing
Ibex Reports Record Fiscal 2026 Financial Performance
Positive
Sep 10, 2026
On September 8, 2026, Ibex Global Solutions and affiliates amended their U.S. and UAE credit agreements with HSBC, extending maturities to October 22, 2029, adding a $1 million performance bond facility, and maintaining $25 million U.S. and $50 mi...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.